Markus R Meyer - JoVE Visualize

Showing results (111-120 of 261) with videos related to

Pageof 27

Sort By:

Drug Testing and Analysis|January 19, 2025

Comprehensive Qualitative Drug Screening in Emergency Toxicology Using an Automated LC-MS<sup>n</sup> System:Simultaneous Quantification of Relevant Drugs and Metabolites in Blood PlasmaSelina Hemmer, Maximilian Ninnig, Lea Wagmann, et al.

Archives of Toxicology|July 5, 2022

Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterasesLea Wagmann, Rebecca G Stiller, Svenja Fischmann, et al.

BMC Anesthesiology|February 20, 2010

The breast feeding mother and xenon anaesthesia: four case reports. Breast feeding and xenon anaesthesiaRalph Stuttmann, Claudia Schäfer, Peter Hilbert, et al.

Journal of Pharmaceutical and Biomedical Analysis|June 12, 2017

Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examplesLilian H J Richter, Veit Flockerzi, Hans H Maurer, et al.

Journal of Chromatography. A|December 18, 2013

Direct analysis of the mushroom poisons α- and β-amanitin in human urine using a novel on-line turbulent flow chromatography mode coupled to liquid chromatography-high resolution-mass spectrometry/mass spectrometryAndreas G Helfer, Markus R Meyer, Julian A Michely, et al.

Analytica Chimica Acta|November 10, 2021

Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MSCathy M Jacobs, Michael Kunz, Felix Mahfoud, et al.

Journal of Analytical Toxicology|June 9, 2020

Studies on the In Vitro and In Vivo Metabolic Fate of the New Psychoactive Substance N-Ethyl-N-Propyltryptamine for Analytical PurposesSascha K Manier, Christina Felske, Josef Zapp, et al.

Journal of Mass Spectrometry : JMS|February 24, 2012

New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urineMarkus R Meyer, Christian Vollmar, Andrea E Schwaninger, et al.

Drug Testing and Analysis|September 7, 2018

Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidasesLea Wagmann, Simon D Brandt, Alexander Stratford, et al.

Analytical and Bioanalytical Chemistry|February 26, 2015

Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniquesJessica Welter, Simon D Brandt, Pierce Kavanagh, et al.

Pageof 27

Showing results (111-120 of 261) with videos related to

Sort By:

Pageof 27

Drug Testing and Analysis|January 19, 2025

Comprehensive Qualitative Drug Screening in Emergency Toxicology Using an Automated LC-MS<sup>n</sup> System:Simultaneous Quantification of Relevant Drugs and Metabolites in Blood PlasmaSelina Hemmer, Maximilian Ninnig, Lea Wagmann, et al.

Archives of Toxicology|July 5, 2022

Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterasesLea Wagmann, Rebecca G Stiller, Svenja Fischmann, et al.

BMC Anesthesiology|February 20, 2010

The breast feeding mother and xenon anaesthesia: four case reports. Breast feeding and xenon anaesthesiaRalph Stuttmann, Claudia Schäfer, Peter Hilbert, et al.

Journal of Pharmaceutical and Biomedical Analysis|June 12, 2017

Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examplesLilian H J Richter, Veit Flockerzi, Hans H Maurer, et al.

Journal of Chromatography. A|December 18, 2013

Direct analysis of the mushroom poisons α- and β-amanitin in human urine using a novel on-line turbulent flow chromatography mode coupled to liquid chromatography-high resolution-mass spectrometry/mass spectrometryAndreas G Helfer, Markus R Meyer, Julian A Michely, et al.

Analytica Chimica Acta|November 10, 2021

Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MSCathy M Jacobs, Michael Kunz, Felix Mahfoud, et al.

Journal of Analytical Toxicology|June 9, 2020

Studies on the In Vitro and In Vivo Metabolic Fate of the New Psychoactive Substance N-Ethyl-N-Propyltryptamine for Analytical PurposesSascha K Manier, Christina Felske, Josef Zapp, et al.

Journal of Mass Spectrometry : JMS|February 24, 2012

New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urineMarkus R Meyer, Christian Vollmar, Andrea E Schwaninger, et al.

Drug Testing and Analysis|September 7, 2018

Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidasesLea Wagmann, Simon D Brandt, Alexander Stratford, et al.

Analytical and Bioanalytical Chemistry|February 26, 2015

Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniquesJessica Welter, Simon D Brandt, Pierce Kavanagh, et al.

Pageof 27